Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients
NCT05332353
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Non-Muscle Invasive Bladder Cancer
Interventions
DRUG:
Bacillus Calmette-Guerin
Sponsor
Mansoura University